Evidence map›Paper›PMID 36820061›Full record

ArticlemicroLife2023

Katrina Madden, Rayan El Hamra, Stefania Berton, Jake Felker, Gonzalo G Alvarez, Alexandre Blais, Jim Sun

Open access · goldAbstract read
In one paragraph

Article in microLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. The role of ATF4 in neurons under mitochondrial stress.NAR genomics and bioinformatics · 2026
    Article
  2. Article
  3. Epigenetic Reprogramming byAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. IFIT2-induced transcriptomic changes inFrontiers in cellular and infection microbiology · 2025
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Katrina MaddenDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.ORCID https://orcid.org/0000-0003-3936-2028
Rayan El HamraDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.
Stefania BertonDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.ORCID https://orcid.org/0000-0003-2961-6100
Jake FelkerDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.
Gonzalo G AlvarezOttawa Hospital Research Institute, Ottawa, Ontario K1Y 4E9, Canada.ORCID https://orcid.org/0000-0003-1562-5305
Alexandre BlaisDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.ORCID https://orcid.org/0000-0003-2446-1883
Jim SunDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada.ORCID https://orcid.org/0000-0002-6873-6052
University of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis, a deadly infectious lung disease caused by

Indexed as

ATAC-seqchromatin accessibilityepigenomehost-directed therapyMycobacterium tuberculosisRNA-seqtranscriptometuberculosistype I IFN

Identifiers

PMID36820061
PMCPMC9936219
OpenAlexW4319299889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.